Kolexia
Debourgogne Anne
Pharmacien
Hôpital Brabois
Vandoeuvre-lès-Nancy, France
63 Activités
0 Followers

Scientifique
Digital
Production scientifique
Activités par an
Expertise
Sujets de recherche
{{person.topmesh1.name}} Mycoses Fusariose Onychomycose Pneumonie à Pneumocystis Sinusite Pneumopathie infectieuse Kératite Échinococcose Maladie aigüe

Industries

Pfizer
2 collaboration(s)
Dernière en 2023
bioMérieux
1 collaboration(s)
Dernière en 2023
{{person.topindus3.name}}
{{person.topindus3.tot}} collaboration(s)
Dernière en {{person.topindus3.last}}
{{person.topindus4.name}}
{{person.topindus4.tot}} collaboration(s)
Dernière en {{person.topindus4.last}}

Dernières activités

FUSIMIR: Multicenter Study on Invasive Fusariosis : Looking for Markers of Infection and Resistance
Essai Clinique (CHU Nancy)   22 février 2024
Combination of serum and peritoneal 1.3-beta-D-glucan can rule out intra-abdominal candidiasis in surgical critically ill patients: a multicenter prospective study.
Critical care (London, England)   30 novembre 2023
Interactions between Bacteria and in Airways: From the Mycobiome to Molecular Interactions.
Journal of fungi (Basel, Switzerland)   01 septembre 2023
Gradient concentration strip-specific epidemiological cut-off values of antifungal drugs in various yeast species and five prevalent Aspergillus species complexes.
Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases   09 décembre 2022
Evaluation of the Bio-Evolution Microsporidia generic and typing real-time PCR assays for the diagnosis of intestinal microsporidiosis.
Parasite (Paris, France)   25 novembre 2022
Simulated Microgravity Created Using a Random Positioning Machine Induces Changes in the Physiology of the Species Complex.
Microorganisms   16 novembre 2022
Mutations in the Species Complex: First Clue to Understand the Low Susceptibility to Azoles of the Genus .
Journal of fungi (Basel, Switzerland)   20 mai 2022
antifungal effect of a plant-based product, CIN-102, on antifungal resistant filamentous fungi and their biofilms.
Journal of medical microbiology   16 septembre 2021
Severe acute respiratory coronavirus virus 2 (SARS-CoV-2) seroprevalence among laboratory staff: Safe handling of coronavirus disease 2019 (COVID-19) samples.
Infection control and hospital epidemiology   21 juillet 2021
Characterisation of the antifungal effects of a plant-based compound, CIN-102, on the main septal filamentous fungi involved in human pathology.
Journal of global antimicrobial resistance   31 mars 2021